Carcinoembryonic antigen (CEA) is normally found in embryonic entodermal epithelium. Carcinoembryonic antigen is a group of glycoprotein present in the body fluids of the fetus and embryo and in the gastrointestinal tract. Carcinoembryonic antigen is also present in the mucosal cells of the colorectum, gastrointestinal cells, and small amounts are present in the blood. Carcinoembryonic antigen is produced by the gastrointestinal tissues during the development of fetal. CEA is not present in the healthy adults but cancer patients show concentrations of CEA. A carcinoembryonic antigen test is generally a blood test that measures the amount of carcinoembryonic antigen protein in the blood. The test is also used to manage and diagnose certain types of cancers like breast cancer, colorectal or colon cancer, cancer of the gastrointestinal tract, liver cancer, ovarian cancer, lung cancer and others. The sensitivity of carcinoembryonic antigen is low for early colon cancer patients. The Carcinoembryonic antigen (CEA) test is especially used for cancers of the rectum and large intestine. Carcinoembryonic antigen is one of the most commonly used tumor markers globally. But its primary significance is in colorectal cancer.
According to WHO, Cancer is the second leading cause of death globally and accounted for 8.8 million death in 2015. Globally, nearly 1 in 6 deaths is due to cancer. Around one third of deaths from cancer are due to the 5 leading behavioral and dietary risks: high body mass index, low fruit and vegetable intake, lack of physical activity, tobacco use, and alcohol use.
Carcinoembryonic Antigen (CEA) Market: Drivers and Restraints
Global carcinoembryonic antigen (CEA) market is expected to grow over the forecast period due to the factors such as rising prevalence of cancer, high demand for minimally invasive diagnostic procedures in cancer and increasing per capita healthcare expenditure. Rapidly increasing geriatric population who are prone to chronic medical conditions including cancer is likely to drive the market growth. In addition, the introduction and constant development of the novel immunological techniques like the radioimmunoassay is expected to increase the demand for carcinoembryonic antigen tests. However, the risk of infections by CEA testing will restrain the market growth of the global carcinoembryonic antigen during the projected period.
Carcinoembryonic Antigen (CEA) Market: Overview
Based on the application type, the global carcinoembryonic antigen (CEA) Market is segmented into colorectal cancer, pancreatic cancer, breast cancer, lung cancer, ovarian cancer and others. Carcinoembryonic antigen (CEA) application in colorectal cancer dominated the overall market. Increasing consumption of alcohol increases the growth of colorectal cancer. Breast cancer is expected to be the fastest growing application segment due to the rising demand for Hormone Replacement Therapy (HRT), increasing number of female population above 50 years and cosmetic surgeries. Based on end user, the global carcinoembryonic antigen market is segmented into hospitals, diagnostic centers, cancer centers and research centers.
For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5528
Carcinoembryonic Antigen (CEA) Market: Key Players
Key players operating in the global carcinoembryonic antigen market include F. Hoffmann-La Roche Ltd, Abbott Diagnostics, Quest Diagnostics, Lee Biosolutions, Inc., and RayBiotech, Inc. Manufacturers face difficult price-based competition and are also under endless pressure to introduce technologically new advanced products.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report covers exhaust analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, ASEAN, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC Countries, S. Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-5528
About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com